Systemic administration of dizocilpine maleate (MK-801) or L-dopa reverses the increases in GAD65 and GAD67 mRNA expression in the globus pallidus in a rat hemiparkinsonian model

Synapse

Volumn 46, Issue 4, 2002, Pages 224-234

  Bacci, Jean Jacques ^a   Salin, Pascal ^a   Goff, Lydia Kerkerian Le ^a  

^a CNRS   (France)

Author keywords

Basal ganglia; Glutamate decarboxylase; In situ hybridization; Levodopa; NMDA antagonist

Indexed keywords

DIZOCILPINE; DOPAMINE; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; LEVODOPA; MESSENGER RNA; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DENERVATION; DRUG EFFECT; FEMALE; GLOBUS PALLIDUS; HISTOCHEMISTRY; IMAGE ANALYSIS; IN SITU HYBRIDIZATION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RAT;

EID: 0037114072     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10117     Document Type: Article

References (50)

1. Albin RL, Makowiec RL, Hollingsworth ZR, Dure LS 4th, Penney JB, Young AB. 1992. Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study. Neuroscience 46:35-48.
2. Anglade P, Mouatt-Prigent A, Agid Y, Hirsch E. 1996. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration 5:121-128.
3. Campbell K, Björklund A. 1994. Prefrontal corticostriatal afferents maintain increased enkephalin gene expression in the dopamine-denervated rat striatum. Eur J Neurosci 6:1371-1383.
4. Cenci MA, Lee CS, Bjorklund A. 1998. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 10:2694- 2706.
5. Chesselet M-F, Delfs J-M. 1996. Basal ganglia and movement disorders: An update. Trends Neurosci 19:417-422.
6. Cox KH, Deleon DV, Angerer LM, Angerer RC. 1984. Detection of mRNA in sea urchin embryos by in-situ hybridization using asymmetric RNA probes. Dev Biol 101:485-502.
7. De Groot. 1959. The Rat Forebrain in Stereotaxic Coordinates. Verhandelingen der Koninklijke Nederlandse Akademic van Wetenschappen. Amsterdam: AFD Natuurkunde N.V. Noord-Hallandsche Wetgevers Maatschappij.
8. Delfs JM, Ciaramitaro VM, Parry TJ, Chesselet M-F. 1995. Subthalamic nucleus lesions: Widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats. J Neurosci 15:6562-6575.
9. Delong MR. 1990. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
10. Duty S, Henry B, Crossman AR, Brotchie JM. 1998. Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat. Exp Neurol 150:223-234.
11. Engber TM, Susel Z, Kuo S, Gerfen CR, Chase TN. 1991. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Brain Res 552:113-118.
12. François C, Savy C, Jan C, Tande D, Hirsh EC, Yelnik J. 2000. Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients. J Comp Neurol 425:121-129.
13. Gauthier J, Parent M, Levesque M, Parent A. 1999. The axonal arborization of single nigrostriatal neurons in rats. Brain Res 834: 228-232.
14. Hajji MD, Salin P, Kerkerian-Le Goff L. 1996a. Chronic dizocilpine maleate (MK-801) treatment suppresses the effects of nigrostriatal dopamine deafferentation on enkephalin but not on substance P expression in rat striatum. Eur J Neurosci 8:917-926.
15. Hajji MD, Salin P, Kerkerian-Le Goff L. 1996b. Repeated injections of dizocilpine maleate (MK-801) do not suppress the effects of nigrostriatal dopamine deafferentation on glutamate decarboxylase (GAD67) mRNA expression in the adult rat striatum. Brain Res Mol Brain Res 43:219-224.
16. Hassani OK, Mouroux M, Feger J. 1996. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience 72:105-115.
17. Hedreen JC. 1999. Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus. J Comp Neurol 409:400-410.
18. Henry B, Crossman AR, Brotchie JM. 1999. Effect of repeated L- DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Exp Neurol 155:204-220.
19. Hirsh EC, Perier C, Orieux G, François C, Feger J, Yelnik J, Vila M, Levy R, Tolosa ES, Marin C, Trinidad Herrero M, Obeso JA, Agid Y. 2000. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci 23(Suppl):S78-S85.
20. 3H-mazindol autoradiography. J Neurosci 5:1513-1521.
21. Kincaid AE, Penney JB Jr, Young AB, Newman SW. 1991. The globus pallidus receives a projection from the parafascicular nucleus in the rat. Brain Res 553:18-26.
22. Kita H, Kitai ST. 1991. Intracellular study of the rat globus pallidus neurons: Membrane properties and responses to neostriatal, subthalamic and nigral stimulation. Brain Res 564:296-305.
23. Laprade N, Soghomonian J-J. 1995. MK-801 decreases striatal and cortical GAD65 mRNA levels. Neuroreport 6:1885-1889.
24. Laprade N, Soghomonian J-J. 1999. Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differentially altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates. Synapse 33:36-48.
25. Lindefors N, Ungerstedt U. 1990. Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons. Neurosci Lett 115:248-252.
26. Lindvall O, Bjorklund A. 1979. Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Brain Res 172:169-173.
27. Maneuf YP, Mitchell IJ, Crossman AR, Brotchie JM. 1994. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Exp Neurol 125:65-71.
28. Mavridis M, Besson MJ. 1999. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression. Neuroscience 92:945-966.
29. Mercugliano M, Soghomonian J-J, Qin Y, Nguyen HQ, Feldblum S, Erlander MG, Tobin AJ, Chesselet M-F. 1992. Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases (Mr 65,000 and Mr 67,000) in the basal ganglia of the rat. J Comp Neurol 318:245-254.
30. Meshul CK, Emre N, Nakamura CM, Allen C, Donohue MK, Buckman JF. 1999. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience 88:1-16.
31. Mouroux M, Feger J. 1993. Evidence that the parafascicular projection to the subthalamic nucleus is glutamatergic. Neuroreport 4:613-615.
32. Mouroux M, Hassani OK, Feger J. 1997. Electrophysiological and Fos immunohistochemical evidence for the excitatory nature of the parafascicular projection to the globus pallidus. Neuroscience 81: 387-397.
33. Nambu A, Tokuno H, Hamada I, Kita H, Imanishi M, Akazawa T, Ikeuchi Y, Hasegawa N. 2000. Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey. J Neurophysiol 84:289-300.
34. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow W. 2000. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 23(Suppl):S8-S19.
35. Orieux G, Francois C, Feger J, Yelnik J, Vila M, Ruberg M, Agid Y, Hirsch EC. 2000. Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease. Neuroscience 97:79-88.
36. Parent A, Hazrati L-N. 1995. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Rev 20:128-154.
37. Parent A, Sato F, Wu Y, Gauthier J, Lévesque M, Parent M. 2000. Organization of the basal ganglia: The importance of axonal collateralization. Trends Neurosci 23(Suppl):S20-S27.
38. Paxinos G, Watson C. 1986. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
39. Pednault S, Soghomonian J-J. 1994. Glutamate decarboxylase (GAD65) mRNA levels in the striatum and pallidum of MPTP-treated monkeys. Brain Res Mol Brain Res 25:351-354.
40. Robledo P, Feger J. 1990. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: Electrophysiological data. Brain Res 518:47-54.
41. Salin P, Dziewczapolski G, Gershanik OS, Nieoullon A, Raisman-Vozari R. 1997. Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat. Brain Res Mol Brain Res 47:311-321.
42. Schroeder JA, Schneider JS. 2001. Alterations in expression of messenger RNAs encoding two isoforms of glutamic acid decarboxylase in the globus pallidus and entopeduncular nucleus in animals symptomatic for and recovered from experimental parkinsonism. Brain Res 888:180-183.
43. Soghomonian J-J, Chesselet M-F. 1992. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse 11:124-133.
44. Soghomonian J-J, Laprade N. 1997. Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of parkinsonian monkeys. Synapse 27:122-132.
45. Soghomonian J-J, Martin DL. 1998. Two isoforms of glutamate decarboxylase: Why? Trends Pharmacol Sci 19:500-505.
46. Starr MS. 1995. Antiparkinsonian actions of glutamate antagonists - Alone and with L-DOPA: A review of evidence and suggestions for possible mechanisms. J Neural Transm Park Dis Dement Sect 10:141-185.
47. Vila M, Levy R, Herrero M-T, Faucheux B, Obeso JA, Agid Y, Hirsch EC. 1996. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study. Neuroscience 71:903-912.
48. Vila M, Levy R, Herrero M-T, Faucheux B, Obeso JA, Agid Y, Hirsh EC. 1997. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and non human primates: An in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 17:765-773.
49. Vila M, Marin C, Ruberg M, Jimenez A, Raisman-Vozari R, Agid Y, Tolosa E, Hirsch E. 1999. Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia. J Neurochem 73:344-352.
50. 3H] glutamate binding in primate brain. J Neurosci Res 27:512-521.